Looking Into a COVID Lung Using Spatial Transcriptomics
As the early weeks of the pandemic unfolded and health care workers struggled to save so many lives, researchers began tracking the path of
Tag : 10x Genomics
1 min read
Proteomics: The Next Truly Massive Investing Opportunity
Blue and red flashing lights pierced the darkness. Michael Behar and his family were on vacation at a remote campsite 10,000 feet up in the Rocky
10x Genomics Unlocks Whole Transcriptome Analysis in FFPE Tissues With New Visium Assay, Now Shipping
Fueling Discovery in Preserved Tissue Samples to Advance Clinical Translational Research PLEASANTON, Calif., June 10, 2021 (GLOBE NEWSWIRE) — 10x
Geisinger awarded $3.6 million to study genetics of cancer
Apr. 29, 2021 Contract with National Cancer Institute will leverage data from Geisinger’s MyCode Community Health Initiative DANVILLE, Pa. – The
6 min read
AGBT 2021 – A Virtual Summary
AGBT 2021 took place virtually this year! But the conference was nevertheless the attention grabber of the week with a twitter storm, active
5 min read
Technological Threefold Way Leads to Biological Wisdom
This company is growing by leaps and bounds in a race with itself to help scientists improve human health. 10x Genomics’ goal is to bring scale and
5 min read
Single Cell Multiomics: Simultaneous Epigenetic and Transcriptional Profiling
A fundamental challenge in biology is precisely linking gene regulatory networks to the gene expression profiles that define unique cell types and
4 min read
Two Seqs Are Better Than One: Gathering Epigenomic and Transcriptomic Data from a Single Cell
The ability to analyze the levels of gene expression within a single-cell has revolutionized the understanding of biology in fields from cancer to
1 min read
Software’s meteoric rise: Have VCs gone too far?
Steve Sloane Contributor Steve Sloane is a partner at Menlo Ventures where he invests in inflection-stage companies. More posts by this
6 min read
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
Veracyte, a company whose tests help physicians make treatment decisions, is adding technology from NanoString to the fold to expand its diagnostic
5 min read
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
Veracyte, a company whose tests help physicians make treatment decisions, is adding technology from NanoString to the fold to expand its diagnostic
11 min read
Nebion Provides Curated Omics Data Combined with Innovative Visualizations for Target Discovery, Indication Finding, and Drug Safety Assessment
For this month’s “Company Spotlight” blog series we are reviewing Nebion, a Swiss bioinformatics company, in an interview with Philip
5 min read
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
Wall Street welcomed three life science companies to the public markets this week. 10x Genomics led the way Wednesday, followed by SpringWorks
5 min read
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
Wall Street welcomed three life science companies to the public markets this week. 10x Genomics led the way Wednesday, followed by SpringWorks
6 min read
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
Biotech news tends to slow down in August but the past seven days have been busy for regulatory decisions. Three drugs and two devices won FDA